NR

Nageswar Rao Palepu

Director Director DIN 00619397
DIN 00619397 First appointment Dec 2003 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Dec 2003
Shareholding value β€’β€’β€’β€’ Premium profile

About Nageswar Rao Palepu

Data last updated:

Nageswar Rao Palepu has 22 years in corporate governance. Formerly with 1 company, such as Therdose Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00619397
Primary Designation Director
First Appointment 19 Dec 2003
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Therdose Pharma Private Limited U24239TG2003PTC042272
Director19 Dec 20032003₹26.66 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Therdose Pharma Private Limited
Premium access

Shareholding and investment profile for Nageswar Rao Palepu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nageswar Rao Palepu

Nageswar Rao Palepu has 22 years in corporate governance. Formerly with 1 company, such as Therdose Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Nageswar Rao Palepu has expertise in General Business.

Nageswar Rao Palepu has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available